These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 10214683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al.
    Kanna B, Abreu-Pacheco H.
    Diabetes Care; 2007 Feb; 30(2):445-6; author reply 446. PubMed ID: 17259531
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep 12; 352(9131):837-53. PubMed ID: 9742976
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Thus to avoid complications of diabetes. To combine early].
    MMW Fortschr Med; 2001 Nov 01; 143(44):60. PubMed ID: 11732409
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical decisions. Management of type 2 diabetes.
    Goldberg RB, Holman R, Drucker DJ.
    N Engl J Med; 2008 Jan 17; 358(3):293-7. PubMed ID: 18199869
    [No Abstract] [Full Text] [Related]

  • 10. Insulin monotherapy vs. combination therapy.
    Ebell MH.
    Am Fam Physician; 2005 Mar 01; 71(5):899. PubMed ID: 15768618
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis.
    Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS.
    Diabetes Obes Metab; 2012 Sep 01; 14(9):803-9. PubMed ID: 22486923
    [Abstract] [Full Text] [Related]

  • 13. Metformin: diamonds are forever.
    Papanas N, Maltezos E, Mikhailidis DP.
    Expert Opin Pharmacother; 2009 Oct 01; 10(15):2395-7. PubMed ID: 19678795
    [Abstract] [Full Text] [Related]

  • 14. [Insulin sparing and metabolic control with metformin-insulin combination].
    Isnard F.
    Journ Annu Diabetol Hotel Dieu; 1997 Oct 01; ():305-25. PubMed ID: 9296986
    [No Abstract] [Full Text] [Related]

  • 15. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR, Silva ME, Machado HA, Fukui RT, Correia MR, Santos RF, Wajchenberg BL, Rocha DM, Rondon MU, Negrão CE, Ursich MJ.
    Diabetes Obes Metab; 2008 Mar 01; 10(3):238-45. PubMed ID: 18269639
    [Abstract] [Full Text] [Related]

  • 16. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB.
    Journ Annu Diabetol Hotel Dieu; 1984 Mar 01; ():183-91. PubMed ID: 6443219
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Stratton IM, Matthews DR.
    Diabet Med; 1997 Aug 01; 14(8):709-10. PubMed ID: 9272603
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.